Testing a new treatment for temporary hair shedding
Treatments studied
Part of Skin clinical trials.
This trial tests a new treatment (DA-001) to reduce hair shedding and help hair grow back in people with telogen effluvium—a temporary hair loss condition. The treatment is applied directly to the scalp, and participants will be followed to see how well it works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with telogen effluvium (a temporary hair shedding condition).
- You are willing to apply the study treatment as directed and attend all study visits.
- You are generally in good health, with no serious medical events in the past 90 days.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
- You have not used any prescription hair treatments on your scalp in the past 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two new topical treatments (DA-002 and DA-005) for hair loss in people with pattern baldness. The goal is to see if they can help hair grow back.
This study tests an experimental treatment called EPI-001 for androgenetic alopecia—the most common type of hair loss affecting men and women. Researchers will measure how well it works by tracking hair growth over time using special photography and scalp analysis.
This trial tests a new topical solution containing dutasteride to treat male pattern baldness. It aims to see if applying the medication directly to the scalp can help regrow hair with fewer side effects than pills.
This trial tests a cosmetic anti-hair loss product in men with early to moderate male pattern baldness. It looks at how well the product works and if it can help slow or reduce hair loss.
This study tests a new medication (N1087) for female pattern hair loss in women aged 18 to 60. It aims to see if the treatment helps regrow hair and is safe.
This trial tests a new medication called ABS-201 for hair loss. It will first see if the medicine is safe in healthy people, then test if it helps those with male or female pattern baldness.
Hear when a new Androgenetic Alopecia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.